Daewoong Pharmaceutical acquires Canadian GMP approval for Nabota factory

The Daewoong Pharmaceutical’s(CEO Seung-Ho Jeon) Nabora factory acquired the cGMP approval from the U.S. FDA on the last 15^th, and acquired the GMP approval from the Health Canada on the 18^th.

Daewoong Pharmaceutical announced on the 24^th that the company received ‘accepted(C: Complaint)’ at the GMP on the 18^th at the Health Canada’s factory inspection conducted between 14 and 18 May for the a...